Nuvectis Pharma, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €98.21M +50.7% €14.98M -154.3% 15.3% +0.58 pp N/A N/A
    (estimated) €65.17M +96.6% -€27.58M +51.0% -42.3% +0.13 pp N/A N/A
    (estimated) €33.15M +∞% -€18.27M -17.9% -55.1% -0.55 pp N/A N/A
    (estimated) €0.00 +NaN% -€22.25M +15.9% N/A N/A N/A
    (estimated) €0.00 +NaN% -€19.19M +18.0% N/A N/A N/A
    €0.00 +NaN% -€16.27M -14.6% N/A -€10.48M -23.2% N/A
    €0.00 -100.0% -€19.06M +18.5% N/A -€13.66M +17.7% N/A
    €127.56K +∞% -€16.08M +45.8% -12,608.7% -130 pp -€11.61M +42.7% -9,100.0% -91 pp
    €0.00 +NaN% -€11.03M +128,760.0% N/A -€8.14M -39,700.0% N/A
    €0.00 -€8.56K N/A €20.55K N/A

    Notifications